Target species
Future breeder turkeys.
Indications for use
For active immunisation of future breeder turkeys:
- As booster vaccination after priming with live vaccines against Newcastle Disease and Turkey Rhinotracheitis to reduce mortality and clinical signs of Newcastle Disease and to induce a specific seroconversion against Newcastle Disease and Turkey Rhinotracheitis in vaccinated birds throughout the laying period.
- As vaccination against Paramyxovirus Type 3 to reduce the decrease in egg production, as demonstrated by challenge at peak lay, and to induce a specific seroconversion against Paramyxovirus Type 3 throughout the laying period.
Onset of immunity: 4 weeks after the first injection.
Duration of immunity: one laying period (demonstrated by serology).
Contra-indications
None.
Special warnings for each target species
None.
Special precautions for use in animals
Vaccinate only healthy animals. Apply usual aseptic procedures. Do not use syringes with natural rubber or butyl elastomer pistons. Do not keep partly used containers – use immediately after opening. Remove from the refrigerator and allow to reach room temperature before using. Shake well before use. TUR-3 may be used with automatic vaccinating equipment. Equipment including needles and syringes must be sterile before use.
Special precautions to be taken by the person administering the product to animals
To the user: This product contains mineral oil. Accidental injection/self-injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. If you are accidentally injected with this product, seek prompt medical advice even if only a very small amount is injected and take the package leaflet with you. If pain persists for more than 12 hours after medical examination, seek medical advice again.
To the physician: This product contains mineral oil. Even if only small amounts have been injected, accidental injection with this product can cause intense swelling, which may, for example, result in ischaemic necrosis and even loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.
Adverse reactions
None.
Use during pregnancy, lactation or lay
This product is not recommended for administration to birds in lay.
Interactions
No information is available on the safety and efficacy of this vaccine when used with any other product. A decision to use this vaccine before or after any other product therefore needs to be decided on a case by case basis.
Amounts to be administered and administration route
One 0.3 ml dose. Shake well before use. Intramuscular route.
Primary vaccination: One injection 8 to 10 weeks before the beginning of lay.
Booster vaccination: One injection 2 to 4 weeks before the beginning of lay.
Overdose
In the double dose overdose study no abnormal local or systemic reactions occurred.
Withdrawal periods
Zero hours/days.